OSTEOTIDE

This brand name is authorized in Nigeria.

Active ingredients

The drug OSTEOTIDE contains one active pharmaceutical ingredient (API):

1	Teriparatide UNII 10T9CSU89I - TERIPARATIDE
	Teriparatide (rhPTH(1-34)) is the active fragment (1-34) of endogenous human parathyroid hormone. Teriparatide is a bone formation agent to treat osteoporosis. The skeletal effects of teriparatide depend upon the pattern of systemic exposure.
	Read more about Teriparatide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0497	Injection	Osteotide Injection INJ 750 mcg/3 mL 3ML	16 RNW-PP-347967 Osteotide Injection TERIPARATIDE (R- HUMAN PARATHYROID HORMONE) INJECTION USP 750MCG/3 ML Teriparatide (r- Human Parathyroid Hormone) Injection USP 750mcg/3 mL, Succinic acid, Sodium Hydroxide, Glycerol, m-Cresol, Water for injection, A6-0497 Drugs Imported Products 3ml POM 1 8/4/2023 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com VIRCHOW BIOTECH PRIVATE LIMITED, NO. 172 PART, GAGILLAPUR, QUTUBULLAPUR, R.R. DISTRICT -500 043, TELANGANA. INDIA., India	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H05AA02	Teriparatide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05A Parathyroid hormones and analogues → H05AA Parathyroid hormones and analogues
Discover more medicines within H05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A6-0497